INO-4700

· Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INO-4700, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers [Phase 2]